Similar pathway knockdown results have been shown in bladder cancer cells (KU-19-19) harboring the AKT1 E17K mutation as well as in other cancer cells that do not contain this mutation (e.g., MDA-MB-453 cells)11. This evidence concerns the gene AKT1 and urinary bladder carcinoma.